General Information of the Compound
Compound ID |
CP0052556
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
Show/Hide
|
||||||||||||||||||
Synonyms |
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol
1,5-Dideoxy-1,5-N-butylimino-D-glucitol
BuDNJ
Butyldeoxynojirimycin
Miglustat
Miglustat (USAN/INN)
Miglustat [USAN]
Miglustat, Hydrochloride
Miglustatum
N-(n-Butyl)deoxynojirimycin
N-(n-butyl)-1,5-dideoxy-1,5-imino-D-glucitol
N-Bu-DNJ
N-Butyl deoxynojirimycin
N-Butyl dnj
N-Butyl-DNJ
N-Butyl-deoxynojirimycin
N-Butyldeoxynojirimycin
N-Butylmoranoline
N-butyl-1-deoxynojirimycin
NB-DNJ
NBV
OGT 918
OGT-918
SC 48334
SC-48334
SC48334
Vevesca
Zavesca
Zavesca (TN)
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C10H21NO4
|
||||||||||||||||||
Molecular Weight |
219.281
|
||||||||||||||||||
Canonical SMILES |
CCCCN1C[C@H](O)[C@@H](O)[C@H](O)[C@H]1CO
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
UQRORFVVSGFNRO-UTINFBMNSA-N
|
||||||||||||||||||
CAS |
134282-77-2
72599-27-0
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound